tradingkey.logo
tradingkey.logo
Search

TherapeuticsMD Inc

TXMD
Add to Watchlist
2.160USD
-0.050-2.26%
Close 07/01, 16:00ETQuotes delayed by 15 min
25.00MMarket Cap
138.82P/E TTM

More Details of TherapeuticsMD Inc Company

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

TherapeuticsMD Inc Info

Ticker SymbolTXMD
Company nameTherapeuticsMD Inc
IPO dateJan 31, 2001
CEOWalker (Marlan D)
Number of employees1
Security typeOrdinary Share
Fiscal year-endJan 31
Address951 Yamato Road, Suite 220
CityBOCA RATON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33431
Phone15619611900
Websitehttps://www.therapeuticsmd.com/
Ticker SymbolTXMD
IPO dateJan 31, 2001
CEOWalker (Marlan D)

Company Executives of TherapeuticsMD Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
141.13K
+47.82%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
141.13K
+47.82%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of TherapeuticsMD Inc?

The top five shareholders of TherapeuticsMD Inc are: Mr. Marlan D. Walker, J.D.

How many institutions hold shares of TherapeuticsMD Inc (TXMD)?

As of 2026Q1, 87 institutions hold shares of TherapeuticsMD Inc, with a combined market value of approximately 3.82M, accounting for 32.99% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 423750.00.